| Category |
Lot(s) |
Qty |
Amount |
Reserved |
| Retail |
1 |
105 |
14700 |
36300 |
| sHNI |
14 |
1470 |
205800 |
370 |
| bHNI |
69 |
7245 |
1014300 |
741 |
Incorporated in 1980, Valiant Laboratories Limited is an Active Pharmaceutical ingredient Manufacturing company in India having focus on manufacturing of Paracetamol.
The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. The company also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.
Valiant Laboratories IPO Details
| Issue Size | 11,556,000 shares
(aggregating up to ₹[152] Cr) |
| Fresh Issue | 11,556,000 shares
(aggregating up to ₹[152] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 32,560,000 |
| Share holding post issue | 44,116,000 |
Valiant Laboratories IPO Reservation
| QIB Shares Offered | Not more than 50.00% of the Net offer |
| NII (HNI) Shares Offered | Not less than 15.00% of the Offer |
| Retail Shares Offered | Not less than 35.00% of the Offer |
Company Financials
Valiant Laboratories IPO Financial Information (Restated Standalone)| Period | Mar 2021 | Mar 2022 | Mar 2023 |
| Assets | 106.31 | 181.81 | 212.76 |
| Revenue | 183.78 | 293.47 | 338.77 |
| Profit | 30.59 | 27.50 | 29.00 |
| Net Worth | 88.58 | 71.46 | 100.49 |
| Reserves | | | |
| Borrowing | 0.35 | 60.68 | 59.40 |
Amount in ₹ Crore
Strength
Weakness
